Gastroenterology XILAPLUS® AF Scientific publication Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial. Lucio Gnessi, Xavier Llop, Núria Piqué. 23rd UEG WEEK BARCELONA. October 24-28 2015 Related publications CPHI 2025 Read New publication on the mode of action of Mucoprotectants: gelatin tannate and xyloglucan show similar effectivity on preventing Cholera Toxin-Induced diarrhea in experimental studies1 Read Tasectan and Xilaplus in the new German GPGN Guidelines Read